FDA Drug Approvals Q1 2024
Medscape,
Hematology/oncology Amtagvi (lifileucel) Lifileucel is a preparation of autologous tumor-infiltrating lymphocytes (TILs…
Hematology/oncology Amtagvi (lifileucel) Lifileucel is a preparation of autologous tumor-infiltrating lymphocytes (TILs…
Omid Hamid, MD, gives his perspective on the use of tumor-infiltrating lymphocyte therapy for patients with melanoma.
Negli Stati Uniti è stata approvatalifileucel, la prima immunoterapia con TIL (tumor-infiltrating lymphocyte, linfociti…
The recently approved immunotherapy Amtagvi uses a patient’s own immune cells to destroy advanced melanoma.